A chapter from a long study (by Esa Mäkeläinen). Please click the corresponding chapter number (3.2.) from the table of contents after you have chosen this link.
A paper that examines the long-run performance of firms adopting EVA-like plans. Written by Cris Hogan and Craig Lewis. Professors from Owen Graduate School of Management, Vanderbilt University.
A paper that tests the correlation between EVA and shareprices and the effectiveness of EVA based compensation plans. Written by following professors: GARY C. BIDDLE, Hong Kong University of Science & Technology; ROBERT M. BOWEN University of Washington; JAMES S. WALLACE University of California, Irvine
A chapter from a long study (by Esa Mäkeläinen). Please click the corresponding chapter number (2.2.3.) from the table of contents after you have chosen this link.
Eli Lilly, maker of Prozac, is among a pioneering group of companies that are tying pay to EVA goals. FORTUNE's Justin Martin spoke with Randall Tobias, the pharmaceutical giant's CEO, to learn how such a system is paying off for the company.